Corbett Keeling Limited
Corbett Keeling Limited describes itself as an independent, London-based corporate finance firm advising private-company owners. It states that it specialises in selling privately owned UK companies valued between £10 million and £150 million, alongside capital raising and acquisition advice.
What stands out about Corbett Keeling Limited
Corbett Keeling Limited publicly positions itself around UK private-company sales in the £10 million to £150 million range, with services spanning sale preparation, buyer mapping, transaction-structure advice, capital raising and acquisitions.[1][2][3][4][7]
What does Corbett Keeling Limited do?
Corbett Keeling Limited describes itself as an independent, London-based corporate finance firm advising private-company owners on selling businesses, raising capital and making acquisitions.
Companies House records identify the firm as an active private limited company incorporated on 22 April 1993 under company number 02811619, with a registered office at 8 Angel Court, London, EC2R 7HP.[1][2]
The firm publicly states that it advises private-company owners on selling their businesses, raising capital and making acquisitions.
Its PRO Review assesses financial performance, operational quality, market position and negotiating strength. The stated outputs include current and optimised valuation assessments, buyer mapping, transaction-structure options and recommended next steps.
For capital raising, Corbett Keeling describes a five-stage process covering PRO Review preparation, process preparation, funder engagement and negotiation, due diligence and legalities, and completion.[1][3][4]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring Corbett Keeling Limited?
For an owner evaluating a sale mandate, the firm’s stated scope includes privately owned UK companies valued between £10 million and £150 million, together with sale preparation, buyer mapping and transaction-structure advice.
The official Valuations page does not publish a universal fee schedule, minimum fee, success-fee percentage, termination fee or tail provision. These engagement terms should therefore be confirmed directly for the proposed mandate.
The Selling Your Business page does not publish consideration amounts for the listed transactions on that page. Owners may wish to request relevant transaction values, structures, proposed buyer coverage, conflicts procedures and the experience of the team proposed for the engagement.[1][3][7]
What exact enterprise-value or equity-value range does the firm currently prioritise, and how does it handle businesses below or above the stated £10 million to £150 million range
What are the proposed retainer, success fee, minimum fee, expense, termination and tail provisions
Which recent transactions were led directly by the proposed team, and what were the transaction values and structures
What size transactions and clients does Corbett Keeling Limited focus on?
The official sectors page lists Consumer, Financial Services, Healthcare, Industrials, Support Services, and Tech, Media, Telecoms.
The healthcare team describes experience across pharmaceuticals, medical devices, healthcare services, healthcare insurance, hospitals and care homes.[5][6]
Corbett Keeling advised the shareholders of TMS Group on its sale to Sullivan Street Partners, announced on 7 April 2025.
It also advised on the sale of Bébécar UK to Baby Central, announced on 1 March 2025, and on the sale of East Coast Nursery to Clair de Lune, announced on 20 February 2025.
In another published example, Corbett Keeling advised Arishta on securing £10 million of debt funding from Growth Lending and completing its acquisition of A & R Care Limited as part of a care-home buy-and-build strategy.[8][9][10][11]
Corbett Keeling’s stated transaction work covers business sales, capital raising and acquisitions for private companies. Its sale-readiness proposition includes buyer mapping and transaction-structure advice, with the firm stating that it seeks an optimal mix of cash, certainty and chemistry for transactions.[1][7]
What does Corbett Keeling Limited publicly disclose about fees, process and engagement terms?
The official Selling Your Business page identifies completed transactions including Oldham Engineering, TMS Group, Bébécar UK and East Coast Nursery but does not publish consideration amounts for those transactions on that page.
The official Valuations page describes the PRO Review and its outputs but does not publish a universal fee schedule, minimum fee, success-fee percentage, termination fee or tail provision on that page.[3][7]
Corbett Keeling Limited states that it is authorised and regulated by the Financial Conduct Authority under FRN 165387.
The firm identifies itself as registered in England and Wales under company number 02811619, with its registered office at 8 Angel Court, London, EC2R 7HP.[12][13]
The firm’s public sale-readiness process includes the PRO Review, buyer mapping and transaction-structure advice. Corbett Keeling states that it achieved an average 40% uplift in sale value compared with clients’ initial expectations and a 90% deal-completion rate.
These performance figures are claims published by the firm; the cited source does not establish the underlying sample, methodology or time period.[1][3][7]
Questions to ask before hiring Corbett Keeling Limited
What exact enterprise-value or equity-value range does the firm currently prioritise, and how does it handle businesses below or above the stated £10 million to £150 million range?
What are the proposed retainer, success fee, minimum fee, expense, termination and tail provisions?
Which recent transactions were led directly by the proposed team, and what were the transaction values and structures?
How would the firm manage a partial sale, rollover equity, earn-out, vendor loan note or management reinvestment?
Which trade buyers, private equity funds, family offices and international buyers would be approached?
What conflicts checks and regulatory permissions apply to the proposed mandate?
Sources & research notes
- Official website / firm overview
- Identity / organization record
- Services / capabilities
- Services / capabilities
- Industry / market focus
- Industry focus
- Investment approach
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Structure / regulatory context
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.